Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), today announced the signing of a definitive Share Purchase Agreement ("SPA") for the acquisition of 100% of Dura Driver Control Systems ("DCS"), a premier designer and manufacturer of automotive driver control systems with expanding industrial applications.